|Hear about pharma trends from Pfizer,
Purdue, and Johnson & Johnson
The Sunshine Act. The 340B Integrity Provision. The Medicare Part D Coverage Act. Pharmaceutical manufacturers have no shortage of compliance concerns to keep an eye on, especially since these regulations can impact contract management and pricing initiatives -- and ultimately an organization’s bottom line. How are companies dealing with these concerns?
Join us on Oct. 2-3 for the Revitas Industry Summit: Life Sciences and you’ll hear from representatives from Pfizer, Purdue, and Johnson & Johnson as they participate in an expert panel with Adam J. Fein, Ph.D.
Two keynotes, by Dr. Fein and Dale Hagemeyer of Gartner, Inc., will illuminate the pharmaceutical market and help organizations focus on the essential forces at work in life sciences today. In addition, there are a number of breakout sessions offering best practices, use cases, and hands-on demonstrations of software to best manage contracts, pricing, and compliance.
If you haven’t already, register for the conference now. For more information on what you can expect to see at the conference, scroll through the press release we issued this morning for the full lineup at Revitas Industry Summit: Life Sciences.